This course is free with an Unlimited CE upgrade!

Upgrade to Premium Unlimited CE and access premium courses over 1.5 contact hours for free.

Upgrade NowLoading..

Goals and Learning Outcomes

Drug-induced kidney and liver injury is a major problem throughout the world. Some of the most commonly prescribed drugs are involved in the pathogenesis of kidney and liver toxicity, including antibiotics, acetaminophen (Tylenol®), non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., ibuprofen [Advil®]), and angiotensin-converting enzyme (ACE) inhibitors. These frequently prescribed medications can result in kidney and liver toxicities, and many are available over the counter. Therefore, it is imperative that healthcare providers are aware of which agents commonly cause kidney or liver injury, symptoms that may indicate toxicity, abnormalities in lab values that indicate kidney or liver injury, and potential preventive measures.

The goal of this course is to provide healthcare professionals with in-depth understanding of common drugs and other agents that are nephrotoxic or hepatotoxic.


After taking this course, you should be able to:

  • Describe each healthcare professionalÂ’s role in the prevention and management of kidney and liver toxicity
  • Identify drugs and supplements that commonly cause kidney and liver toxicity
  • Describe the pathogenesis for drug-induced kidney and liver injury
  • State abnormalities in lab results that may indicate kidney and liver toxicity
  • Discuss prophylactic strategies to prevent kidney or liver injury
  • Examine the roles of healthcare professionals in the prevention and management of kidney and liver toxicity.
  • Identify drugs and supplements that commonly cause kidney and liver toxicity.
  • Express the pathogenesis for drug­induced kidney and liver injury.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/24

Course Originally Released On: 08/01/21

Course Authors

4.4 Average

Course Reviews

3234 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.